Your browser doesn't support javascript.
loading
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane.
Willemsen, Annelieke E C A B; de Geus-Oei, Lioe-Fee; de Boer, Maaike; Tol, Jolien; Kamm, Yvonne; de Jong, Paul C; Jonker, Marianne A; Vos, Allert H; Grootjans, Willem; de Groot, Johannes W B; Mulder, Sasja F; Aarntzen, Erik H J G; Gerritsen, Winald R; van Herpen, Carla M L; van Erp, Nielka P.
Afiliación
  • Willemsen AECAB; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands.
  • de Geus-Oei LF; Department of Radiology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
  • de Boer M; Biomedical Photonic Imaging Group, MIRA Institute, University of Twente, Enschede, the Netherlands.
  • Tol J; Division of Medical Oncology, Department of Internal Medicine, GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Kamm Y; Department of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
  • de Jong PC; Department of Medical Oncology, Maasziekenhuis Pantein, Boxmeer, the Netherlands.
  • Jonker MA; Department of Medical Oncology, St. Antonius Ziekenhuis, Utrecht, the Netherlands.
  • Vos AH; Department for Health Evidence, Radboud university medical center, Nijmegen, the Netherlands.
  • Grootjans W; Department of Medical Oncology, Bernhoven Ziekenhuis, Uden, the Netherlands.
  • de Groot JWB; Department of Radiology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
  • Mulder SF; Isala Oncology Center, Zwolle, the Netherlands.
  • Aarntzen EHJG; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands.
  • Gerritsen WR; Department of Radiology and Nuclear Medicine, Radboud university medical center, Nijmegen, the Netherlands.
  • van Herpen CML; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands.
  • van Erp NP; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands.
Target Oncol ; 13(5): 641-648, 2018 10.
Article en En | MEDLINE | ID: mdl-30259313
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Everolimus / Androstadienos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Target Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Everolimus / Androstadienos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Target Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article